The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells
- PMID: 18762809
- DOI: 10.1038/onc.2008.317
The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells
Abstract
The Rho family of small GTPases control cell migration, cell invasion and cell cycle. Many of these processes are perturbed in cancer and several family members show altered expression in a number of tumor types. RhoBTB2/DBC2 is an atypical member of this family of signaling proteins, containing two BTB domains in addition to its conserved Rho GTPase domain. RhoBTB2 is mutated, deleted or silenced in a large percentage of breast and lung cancers; however, the functional consequences of this loss are unclear. Here we use RNA interference in primary human epithelial cells to mimic the loss of RhoBTB2 seen in cancer cells. Through microarray analysis of global gene expression, we show that loss of RhoBTB2 results in downregulation of CXCL14-a chemokine that controls leukocyte migration and angiogenesis, and whose expression is lost through unknown mechanisms in a wide range of epithelial cancers. Loss of RhoBTB2 expression correlates with loss of CXCL14 secretion by head and neck squamous cell carcinoma cell lines, whereas reintroduction of RhoBTB2 restores CXCL14 secretion. Our studies identify CXCL14 as a gene _target of RhoBTB2 and support downregulation of CXCL14 as a functional outcome of RhoBTB2 loss in cancer.
Similar articles
-
Ectopic expression of RhoBTB2 inhibits migration and invasion of human breast cancer cells.Cancer Biol Ther. 2010 Dec 1;10(11):1115-22. doi: 10.4161/cbt.10.11.13431. Epub 2010 Dec 1. Cancer Biol Ther. 2010. PMID: 20930524
-
RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells.Gene. 2011 Oct 15;486(1-2):74-80. doi: 10.1016/j.gene.2011.07.018. Epub 2011 Jul 23. Gene. 2011. PMID: 21801820
-
Regulation of RhoBTB2 by the Cul3 ubiquitin ligase complex.Methods Enzymol. 2008;439:103-9. doi: 10.1016/S0076-6879(07)00408-9. Methods Enzymol. 2008. PMID: 18374159
-
The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses.Mol Carcinog. 2020 Jul;59(7):794-806. doi: 10.1002/mc.23188. Epub 2020 Mar 24. Mol Carcinog. 2020. PMID: 32212206 Free PMC article. Review.
-
Rho proteins and cancer.Breast Cancer Res Treat. 2004 Mar;84(1):13-9. doi: 10.1023/B:BREA.0000018423.47497.c6. Breast Cancer Res Treat. 2004. PMID: 14999150 Review.
Cited by
-
The epigenetic regulation of CXCL14 plays a role in the pathobiology of oral cancers.J Cancer. 2017 Aug 25;8(15):3014-3027. doi: 10.7150/jca.21169. eCollection 2017. J Cancer. 2017. PMID: 28928893 Free PMC article.
-
BTB protein family and human breast cancer: signaling pathways and clinical progress.J Cancer Res Clin Oncol. 2023 Nov;149(17):16213-16229. doi: 10.1007/s00432-023-05314-9. Epub 2023 Sep 8. J Cancer Res Clin Oncol. 2023. PMID: 37682360 Review.
-
The tumor suppressor RhoBTB1 controls Golgi integrity and breast cancer cell invasion through METTL7B.BMC Cancer. 2017 Feb 20;17(1):145. doi: 10.1186/s12885-017-3138-3. BMC Cancer. 2017. PMID: 28219369 Free PMC article.
-
CXCL14 as an emerging immune and inflammatory modulator.J Inflamm (Lond). 2016 Jan 5;13:1. doi: 10.1186/s12950-015-0109-9. eCollection 2016. J Inflamm (Lond). 2016. PMID: 26733763 Free PMC article. Review.
-
Antimicrobial activities of chemokines: not just a side-effect?Front Immunol. 2012 Jul 23;3:213. doi: 10.3389/fimmu.2012.00213. eCollection 2012. Front Immunol. 2012. PMID: 22837760 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
